December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S (NY: NVO )

72.83 USD +0.31 (+0.43%)
Official Closing Price Updated: 6:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Novo Nordisk A/S

< Previous 1 2
...
48 49 50 51 52 53 54 55 Next >
Novo Nordisk to Build $400 Million China Manufacturing Plant
Novo Nordisk will invest almost $400 million to build a very large insulin manufacturing facility in Tianjin. The new facility will function as the company’s primary production site in China and serve... 
From ChinaBio® Today
Novo Nordisk Launches Levemir(R) Satisfaction Guarantee Program
Satisfied or Their Money Back 
From Marketwired News Releases
New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide Is More Effective Than Exenatide in Treatment of Type 2 Diabetes
From Marketwired News Releases
Novo Nordisk A/S: Treasury Stock
From Marketwired News Releases
Novo Nordisk: Confident In Franchise Sustainability
Novo Nordisk: Confident In Franchise Sustainability 
Tags Health Care
From FOX Business
Novo Nordisk Reports Positive Results For Diabetes Drug
Novo Nordisk Reports Positive Results For Diabetes Drug 
Tags Health Care
From FOX Business
Data From One-Year Liraglutide Phase 3 Study Published Online in The Lancet
From Marketwired News Releases
Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
From PR Newswire
Neose Technologies to Sell its Assets to Novo Nordisk and BioGeneriX
From Business Wire News Releases
MannKind Keeps the Faith in Inhaled Insulin With Opening of $114 Million Production Plant in Connecticut, an Industrial Info News Alert
From Marketwired News Releases
Novo Nordisk: Phase 3 Study Of Liraglutide Showed Benefits
Novo Nordisk: Phase 3 Study Of Liraglutide Showed Benefits 
Tags Health Care
From FOX Business
Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
From PR Newswire
Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Abstract 898 
From Marketwired News Releases
Reichhold to Build $40 Million Polyester Resins Project in China, an Industrial Info News Alert
From Marketwired News Releases
Novo Nordisk Trades Lower On Concerns Over Diabetes Drug
Novo Nordisk Trades Lower On Concerns Over Diabetes Drug 
Tags Health Care
From FOX Business
Emisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results
From PR Newswire
Novo Nordisk Net Profit Slips, Ups Operating Profit Guidance
Novo Nordisk Net Profit Slips, Ups Operating Profit Guidance 
Tags Health Care
From FOX Business
Treasury Stock
From Marketwired News Releases
Emisphere Announces License Agreement With Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonists for Diabetes
From PR Newswire
Transaction in Own Shares
Reduction of the share capital and status of holding of own shares 
From Marketwired News Releases
/C O R R E C T I O N -- Novo Nordisk/
From PR Newswire
New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) Is as Effective as Glargine Over a 24-Hour Period in Subjects With Type 2 Diabetes
New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) Is as Effective as Glargine Over a 24-Hour Period in Subjects With Type 2 Diabetes 
Tags Health Care
From FOX Business
Novo Nordisk and Neose Announce Completion of Initial Phase 1 Clinical Trial of NN7128 (Long-Acting Factor VIIa)
From Business Wire News Releases
Neose Receives Milestone Payment from Novo Nordisk on Factor IX Program
From Business Wire News Releases
The Week in Review: Investment Capital for China Biopharma
Zero2IPO published its quarterly figures on venture capital in China, showing that investment in the Biotech/Healthcare sector jumped 33% in the first quarter to $67 million; Frontage Laboratories... 
From ChinaBio® Today
Novo Nordisk Donates Compound Library to China Center
Novo Nordisk donated a license for its very extensive small-molecule compound library to the National Center for Drug Screening (NCDS), which is affiliated with the Shanghai Institute of Materia... 
From ChinaBio® Today
Novo Nordisk A/S -- Treasury Stock
Status re Novo Nordisk's holding of its own shares (31 March 2008) 
From Marketwired News Releases
FDA Approves NovoLog(R) for Use in Insulin Pumps by Children and Adolescents
Data Demonstrates Efficacy and Safety for Patients aged 4 to 18 
From Marketwired News Releases
Versata Announces Acquisition of NUVO
From Marketwired
NUVO Shareholders Approve Versata Transaction
From Marketwired
< Previous 1 2
...
48 49 50 51 52 53 54 55 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.